FDA.reportPublic FDA data

clobetasol propionate 0.5 MG/ML Ophthalmic Suspension [Byqlovi]

RxCUI
2733663
RxNorm name
clobetasol propionate 0.5 MG/ML Ophthalmic Suspension [Byqlovi]
Display name
clobetasol propionate 0.5 MG/ML Ophthalmic Suspension [Byqlovi]
Full name
clobetasol propionate 0.5 MG/ML Ophthalmic Suspension [Byqlovi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BYQLOVICLOBETASOL PROPIONATEHarrow Eye, LLC31ca5a0f-812e-491d-aa00-d8ed424ba3222026-01-26Warnings, Adverse reactionsExact identifier
rxcui: 2733663

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
31ca5a0f-812e-491d-aa00-d8ed424ba322clobetasol propionate 0.5 MG/ML Ophthalmic Suspension [Byqlovi]SBD3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use Initial U.S. Approval: 198520260126
31ca5a0f-812e-491d-aa00-d8ed424ba322Byqlovi 0.05 % Ophthalmic SuspensionSY3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use Initial U.S. Approval: 198520260126
31ca5a0f-812e-491d-aa00-d8ed424ba322BYQLOVI 0.05 % Ophthalmic SuspensionPSN3These highlights do not include all the information needed to use BYQLOVI ® safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use Initial U.S. Approval: 198520260126